阿瑞匹坦胶囊主要治什么，阿瑞匹坦胶囊说明书

Aprepitant, also known as acetaminidazole or yimei, can be administered in combination with other antiemetic drugs. It is a dose-dependent CYP3A4 inhibitor. The drug is an NK1 receptor antagonist developed and marketed by Merck. Today we will learn in detail what aprepitant capsules mainly treat? Aprepitant capsule instructions.

Full name of the drug: Aprepitant, Aprepitant, Aprepitant capsules, Emend.

Drug Indications: This drug is suitable for the prevention of acute and delayed nausea and vomiting during initial and repeated treatment of highly emetogenic anti-tumor chemotherapy. Aprepitant capsules are administered in combination with other antiemetic drugs.

Adverse drug reactions: increased liver index ALT, constipation, burping, weakness/tiredness, headache and anorexia.

Other adverse reactions include: redness, weakness, pelvic pain, upper respiratory tract infection, tachycardia, rash, hypokalemia, bone pain, pain, anxiety, etc. Orientation disorder, bradycardia, perforated duodenal ulcer, and Stevens-Johnson syndrome have also been reported.

Drug mechanism: Aprepitant is a receptor for the human substance P Neurokinin1 (NK1). It is a selective and high-affinity antagonist. It has a unique mode of action and has a relatively long effect on the central system. It can inhibit the acute and delayed vomiting caused by cisplatin.

Drug purchase price: Aprepitant capsules can be purchased in domestic hospital pharmacies, and can be reimbursed by medical insurance, which reduces the patient's financial burden. However, patients can consult the local medical insurance bureau for specific reimbursement. Patients can also obtain drugs through overseas medical service organizations (such as Medical Companion Travel), which are guaranteed to be genuine. Moreover, consulting the Medical Companion Travel Service staff can also learn the details of many oncology drugs, including whether generic drugs are available and the prices of generic drugs. For specific information, patients can consult the Medical Companion Travel Service staff.

Aprepitant is the first highly selective affinity antagonist of the substance p neurokinin 1 (NK-1) receptor, and patients can use the drug with confidence.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: